Voluntary Recall Information
Philips Respironics Sleep and Respiratory Care devices
News and Updates > Ventilation news and updates
Ventilation remediation news and updates
We are working on the remediation plan for mechanical ventilator devices and have made progress on the production of RP kits. Philips Respironics will partner with DMEs, and provide resources and updates as they are available.
For patients and caregivers with an affected ventilation device
If you are a patient or caregiver with an affected Philips Respironics ventilation device, you do not need to take any action at this time. All ventilation remediation will be done via your Durable Medical Equipment provider (DME). Please contact them if you have any questions.
Ozone and UV light cleaning products are not currently approved cleaning methods for sleep apnea devices or masks and should not be used.
Latest updates
Trilogy Evo Platform Flow Sensor Nebulized Aerosol Deposition Medical Device Correction
October 7, 2024 Philips Respironics has become aware of a potential issue when using in-line nebulizers in certain configurations with Trilogy Evo, Trilogy Evo O2, Trilogy Evo Universal (US) and Trilogy EV300 devices. The use of in-line nebulizers placed in certain locations can result in aerosol deposits accumulating over time on the device’s internal flow sensor. Impacted flow sensors may result in inaccurate flow measurements in certain circumstances. For more information including under what circumstances this issue can occur as well as actions for customers, please click here.
Trilogy 100/200 Financial compensation option
March 20, 2024 We continue to work on remediation pathways for affected Trilogy 100/200 devices. Business customers (i.e., Durable Medical Equipment providers, hospitals and other institutions) now have the option to select financial compensation in exchange for their affected Trilogy 100/200 devices, instead of waiting for remediation via technical/service correction once available.
The financial compensation amount per device will be based on the age of the device at the time of the recall announcement (June 14, 2021). If you elect financial compensation, you must work directly with Philips Respironics to make the election and coordinate the return of your affected device(s). The device(s) must be returned and received by Philips Respironics in order for the financial compensation to be issued.
Business customers with affected Trilogy 100/200 devices will receive a communication from Philips Respironics containing a Trilogy Information Request Form for electing the financial compensation option. In the interim, if you have any questions on the financial compensation option please contact src.trilogyremediation@philips.com.
-
![Medical Device Recall: Interruptions and/or loss of therapy due to Ventilation Inoperative Alarm]()
Medical Device Recall: Interruptions and/or loss of therapy due to Ventilation Inoperative Alarm
May 28, 2024
Click here to learn more -
![Update related to Trilogy Evo platform of ventilators]()
-
![Trilogy 100/200 ship hold - Customer update]()
-
![Trilogy Remediation Update for Business Customers]()
-
![Information for business customers on Bacteria Filters for Trilogy 100 and 200]()
Information for business customers on Bacteria Filters for Trilogy 100 and 200
April 5, 2022
Click here to learn more
